Published in Hum Mol Genet on September 01, 2001
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A (2002) 2.82
Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res (2004) 1.89
Rap1 prevents telomere fusions by nonhomologous end joining. EMBO J (2005) 1.87
Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev (2005) 1.84
Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol (2009) 1.45
Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol Cell Biol (2005) 1.44
Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc Natl Acad Sci U S A (2009) 1.27
Functional interaction between poly(ADP-Ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2. Mol Cell Biol (2004) 1.27
Telomerase extracurricular activities. Proc Natl Acad Sci U S A (2002) 1.20
Allele-specific relative telomere lengths are inherited. Hum Genet (2006) 1.18
Telomeric circles: universal players in telomere maintenance? Nat Struct Mol Biol (2009) 1.10
Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics (2011) 1.08
Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res (2014) 1.05
Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo. Clin Cancer Res (2008) 1.04
Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres. PLoS One (2012) 1.04
The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia (2011) 1.00
PML body meets telomere: the beginning of an ALTernate ending? Nucleus (2012) 0.94
The human telomerase RNA component, hTR, activates the DNA-dependent protein kinase to phosphorylate heterogeneous nuclear ribonucleoprotein A1. Nucleic Acids Res (2009) 0.94
p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance. Mol Cell Biol (2004) 0.93
Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus. Oncogene (2013) 0.92
Telomere lengths in human oocytes, cleavage stage embryos and blastocysts. Mol Hum Reprod (2010) 0.90
Telomeric recombination induced by dysfunctional telomeres. Mol Biol Cell (2010) 0.89
Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth. Oncogene (2013) 0.89
Cell proliferation in the presence of telomerase. PLoS One (2009) 0.88
Telomere regulation in pluripotent stem cells. Protein Cell (2014) 0.86
Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo. Mol Cancer Ther (2010) 0.86
Human telomerase activity, telomerase and telomeric template expression in hepatic stem cells and in livers from fetal and postnatal donors. Eur J Gastroenterol Hepatol (2009) 0.85
Telomerase activity in colorectal cancer, prognostic factor and implications in the microsatellite instability pathway. World J Gastroenterol (2007) 0.84
Telomerase-independent paths to immortality in predictable cancer subtypes. J Cancer (2012) 0.84
Function, replication and structure of the mammalian telomere. Cytotechnology (2004) 0.84
Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies. Am J Pathol (2013) 0.82
Telomere maintenance mechanisms in cancer: clinical implications. Curr Pharm Des (2014) 0.82
Intratumoral diversity of telomere length in individual neuroblastoma tumors. Oncotarget (2015) 0.82
Telomere and Telomerase Therapeutics in Cancer. Genes (Basel) (2016) 0.81
A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res (2005) 0.81
Molecular and cellular evidence for the alternative lengthening of telomeres (ALT) mechanism in chicken. Cytogenet Genome Res (2011) 0.80
Recombination can either help maintain very short telomeres or generate longer telomeres in yeast cells with weak telomerase activity. Eukaryot Cell (2011) 0.79
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis. Transl Oncol (2013) 0.79
Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis. Mutat Res Rev Mutat Res (2014) 0.78
Targeting DNA-PKcs and telomerase in brain tumour cells. Mol Cancer (2014) 0.77
Recombinogenic telomeres in diploid Sorex granarius (Soricidae, Eulipotyphla) fibroblast cells. Mol Cell Biol (2014) 0.75
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences. Cell Death Dis (2017) 0.75
UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo. Oncotarget (2016) 0.75
Inter-telomeric recombination is present in telomerase-positive human cells. Cell Cycle (2013) 0.75
Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma. Biomed Res Int (2015) 0.75
Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX. Sci Rep (2016) 0.75
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA. Proc Natl Acad Sci U S A (1977) 4.35
Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A (1994) 3.86
A rapid and efficient procedure for the purification of DNA from agarose gels. Anal Biochem (1980) 3.77
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun (1982) 3.02
Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol (1994) 2.76
Telomerase activity in normal leukocytes and in hematologic malignancies. Blood (1995) 2.71
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol (1994) 2.57
The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet (1999) 2.52
Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans. J Virol (1985) 2.40
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies. J Virol (1982) 2.24
Selective assay for herpes simplex viruses expressing thymidine kinase. J Virol (1979) 2.03
The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet (1997) 1.97
Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. J Virol (1981) 1.94
Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res (1996) 1.87
Herpes simplex virus thymidine kinase transcripts are absent from both nucleus and cytoplasm during infection in the presence of cycloheximide. J Virol (1980) 1.86
Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res (1995) 1.69
Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology (1991) 1.66
Mapping of a 14,000-dalton antigen to early region 4 of the human adenovirus 5 genome. J Virol (1983) 1.64
Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol (2000) 1.60
Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst (1996) 1.57
Partial purification and characterization of the ribonucleotide reductase induced by herpes simplex virus infection of mammalian cells. J Virol (1981) 1.55
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J Biol Chem (2000) 1.49
Tn5 mutagenesis of the transforming genes of human adenovirus type 5. Gene (1983) 1.41
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer (2010) 1.39
Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol (1997) 1.38
Telomerase activity in normal and malignant murine tissues. Oncogene (1995) 1.34
Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer (1998) 1.34
Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene (2001) 1.31
Herpes simplex virus-induced ribonucleotide reductase: development of antibodies specific for the enzyme. J Gen Virol (1983) 1.29
A UV-specific endonucleolytic activity present in human cell extracts. Biochem Biophys Res Commun (1972) 1.29
Is ribonucleotide reductase the transforming function of herpes simplex virus 2? Nature (1983) 1.26
Immunological characterization of herpes simplex virus type 1 and 2 polypeptide(s) involved in viral ribonucleotide reductase activity. J Virol (1984) 1.24
Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology (1989) 1.23
Production of hybrid cell lines secreting antibodies to herpes simplex virus type 2. J Virol Methods (1981) 1.22
Integration and expression of viral DNA in cells transformed by host range mutants of adenovirus type 5. J Virol (1982) 1.20
Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase. J Virol (1986) 1.18
Covalently closed circles of adenovirus 5 DNA. Nature (1983) 1.17
Genetic interactions between error-prone and error-free postreplication repair pathways in Saccharomyces cerevisiae. Mutat Res (1999) 1.16
Purification and characterization of an endonuclease from calf thymus acting on irradiated DNA. Biochim Biophys Acta (1975) 1.13
Actinomycin D: effects on mouse L-cells. Biophys J (1969) 1.13
The relation of protein synthesis to radiation-induced division delay in Chinese hamster cells. Radiat Res (1970) 1.09
Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg (2001) 1.09
Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells. J Gen Virol (1990) 1.03
Establishment and characterization of hamster cell lines transformed by restriction endonuclease fragments of adenovirus 5. J Virol (1984) 0.98
High frequency recombination between loxP sites in human chromosomes mediated by an adenovirus vector expressing Cre recombinase. Somat Cell Mol Genet (1995) 0.97
Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells. Hum Mol Genet (1998) 0.97
Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology (1988) 0.96
Relation of Herpes simplex viruses to human malignancies. Curr Top Microbiol Immunol (1977) 0.96
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis (2002) 0.95
Telomeres and telomerase in human cancer (review). Int J Oncol (1995) 0.95
The pattern of chromosome-specific variations in telomere length in humans shows signs of heritability and is maintained through life. Ann N Y Acad Sci (2006) 0.95
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. Gene Ther (2003) 0.94
Construction of a recombinant adenovirus for efficient delivery of the I-SceI yeast endonuclease to human cells and its application in the in vivo cleavage of chromosomes to expose new potential telomeres. Nucleic Acids Res (1999) 0.92
Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma. Int J Cancer (1985) 0.92
Quantitative analysis of regions of adenovirus E1A products involved in interactions with cellular proteins. Biochem Cell Biol (1993) 0.91
Chromosomal damage induced by human adenovirus type 12 requires expression of the E1B 55-kilodalton viral protein. J Virol (1990) 0.91
Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines. Oncogene (1998) 0.87
Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53. Oncogene (1994) 0.87
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
Transformation by human adenoviruses. J Cell Physiol Suppl (1984) 0.86
Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome. Mol Cell Biol (1993) 0.85
Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer (1994) 0.84
Synergism between aphidicolin and adenoviruses in the induction of breaks at fragile sites on human chromosomes. Cancer Genet Cytogenet (1991) 0.83
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex. Mol Endocrinol (2011) 0.83
Characterization of human TK- cell lines transformed to a TK+ phenotype by herpes simplex virus type 2 DNA. J Gen Virol (1979) 0.82
Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp Cell Res (1998) 0.82
The transcriptionally competent U2 gene is necessary and sufficient for adenovirus type 12 induction of the fragile site at 17q21-22. Mol Cell Biol (1995) 0.81
Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells. Exp Cell Res (2001) 0.81
Protein kinase and ATP-binding activity associated with the 72-kdalton single-stranded DNA-binding protein from early region 2A of human adenovirus type 5. Can J Biochem Cell Biol (1985) 0.80
Telomeres in the haemopoietic system. Ciba Found Symp (1997) 0.78
The responsiveness of human papillomavirus upstream regulatory regions to herpes simplex virus immediate early proteins. Virus Res (1988) 0.78
In cell lines constitutively synthesizing a temperature-sensitive ICP4 protein of herpes simplex virus type 1, amount and function of ICP4 are both regulated by temperature. Virology (1987) 0.78
Automated continuous culture of mammalian cells in suspension. Science (1970) 0.77
Natural history of the neoplastic locoregional disease: clinical and pathological patterns. J Exp Clin Cancer Res (2003) 0.77
Induction of fragility at the human RNU2 locus by cytosine arabinoside is dependent upon a transcriptionally competent U2 small nuclear RNA gene and the expression of p53. Somat Cell Mol Genet (1997) 0.77
Telomeres and telomerase in normal and malignant haematologic cells. Leuk Lymphoma (1996) 0.77
Hepatic arterial infusion (HAI) for unresectable liver metastases (ULM) from colorectal carcinoma. Tumori (1997) 0.77
Epiadryamicin concentration in experimental hepatic metastases after bolus or continous infusion through systemic or locoregional routes. J Exp Clin Cancer Res (2003) 0.76
Thyroid disease and retinitis pigmentosa. J Endocrinol Invest (1996) 0.75
Recovery from x-ray-induced sub-lethal damage in Saccharomyces cerevisiae cells of different ploidy. Int J Radiat Biol Relat Stud Phys Chem Med (1966) 0.75
DNA-mediated transfer of herpes simplex virus TK gene to human TK- cells: properties of the transformed lines. IARC Sci Publ (1978) 0.75
Relationship between recovery from sublethal damage by dose fractionation and the restoration of viability after delayed plating in diploid Saccharomyces cerevisiae. Radiat Res (1966) 0.75
The effect of x rays on the uptake of 3H-leucine in synchronized Chinese hamster cells. ANL-7635. ANL Rep (1969) 0.75
An attempt to grow HeLa cells in an Eisler-Webb nephelostat. ANL-7635. ANL Rep (1969) 0.75
Radiosensitivity in relation to the cell cycle and recovery from x-ray sublethal damage in diploid yeast. Exp Cell Res (1967) 0.75
Studies on DNA repair in mammalian cells: an endonuclease which recognizes lesions in DNA. Basic Life Sci (1975) 0.75
The effect of irradiation with ultraviolet light on the sedimentation behaviour of PM2 DNA. Photochem Photobiol (1976) 0.75
Studies on transformation of mammalian cells by human adenovirus type 5 (Ad5) and Ad5 DNA. Prog Clin Biol Res (1983) 0.75
An assay for ribonucleotide reductase based on ion-exchange chromatography of the reaction product. Anal Biochem (1985) 0.75
The effects of x-rays on the synthesis of DNA, RNA, and proteins in synchronized Chinese hamster cells. Radiat Res (1971) 0.75
Cycloheximide- and radiation-induced division delay in synchronized Chinese hamster cells. ANL-7635. ANL Rep (1969) 0.75